Showing results (1-10 of 221) with videos related to
Sort By:
Pageof 23
Current Opinion in Hematology|July 17, 2004
Antiphospholipid antibodies: update on detection, pathophysiology, and treatmentPhilip G de Groot, Ronald H W M DerksenSeminars in Thrombosis and Hemostasis|September 25, 2008
Twenty-two years of failure to set up undisputed assays to detect patients with the antiphospholipid syndromePhilip G de Groot, Ronald H W M Derksen, Bas de LaatClinical Immunology (Orlando, Fla.)|July 9, 2004
beta2-glycoprotein I, the playmaker of the antiphospholipid syndromeH Bas de Laat, Ronald H W M Derksen, Philip G de GrootBlood|October 28, 2004
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosisBas de Laat, Ronald H W M Derksen, Rolf T Urbanus, et al.Blood|August 19, 2004
beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndromeH Bas de Laat, Ronald H W M Derksen, Rolf T Urbanus, et al.Blood|October 24, 2002
Oral anticoagulation reduces activated protein C less than protein C and other vitamin K-dependent clotting factorsMarleen J A Simmelink, Philip G de Groot, Ronald H W M Derksen, et al.Blood|November 5, 2005
Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational changeBas de Laat, Ronald H W M Derksen, Menno van Lummel, et al.British Journal of Haematology|May 25, 2002
Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor IIMarleen J A Simmelink, José A Fernández, Ronald H W M Derksen, et al.Blood|October 21, 2006
Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5Bas de Laat, Xiao-Xuan Wu, Menno van Lummel, et al.The Journal of Biological Chemistry|June 17, 2003
Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'Bianca C H Lutters, Ronald H W M Derksen, Winnie L Tekelenburg, et al.Pageof 23